Genomic

Dataset Information

0

CGEMS Prostate Cancer GWAS - Stage 1 - PLCO

ABSTRACT:

The Cancer Genetic Markers of Susceptibility (CGEMS) prostate cancer genome-wide association study (GWAS) included genotyping approximately 550,000 SNPs (Phase 1A with HumanHap300 and Phase 1B HumanHap240, both from Illumina, San Diego, CA) in 1,172 prostate cancer patients and 1,157 controls of European ancestry from the Prostate, Lung, Colon and Ovarian (PLCO, http://www.cancer.gov/prevention/plco/) Cancer Screening Trial. The original analysis published in Nature Genetics [PMID: 17401363] included 2,282 subjects. After improvement and revisions of the original analysis, 2,252 subjects were submitted to dbGaP.

PROVIDER: phs000207 | dbGaP |

SECONDARY ACCESSION(S): PRJNA75549PRJNA75551

REPOSITORIES: dbGaP

Json Xml

Dataset's files

Source:
Action DRS
README.txt Txt
phs000207.v1.p1.CGEMS_ProstateCancer.analysis-PI.MULTI.update.tar.gz Other
phs000207.pha002877.txt.gz Txt
phs000207.pha002878.txt.gz Txt
GapExchange_phs000207.v1.p1.xml Xml
Items per page:
1 - 5 of 23

Similar Datasets

Genomics Cancer Genetic Markers of Susceptibility (CGEMS) Prostate Cancer Genome-Wide Association Study (GWAS) - Primary Scan (Stage 1) - PLCO Screening Trial
| phs000207.v1.p1 | EGA
Genomics CGEMS Prostate Cancer
| PRJNA75549 | ENA
Genomics Homo sapiens
| PRJNA75551 | ENA
Genomics Homo sapiens
| PRJNA316639 | ENA
Genomics Homo sapiens
| PRJNA75419 | ENA
Genomics Homo sapiens
| PRJNA75417 | ENA
Proteomics Time-Dependent Proteome Study: Human ovarian cancer tumor samples (0, 5, 30, 60 min)
2018-11-05 | MSV000083107 | MassIVE
Transcriptomics Transcription profiling by array of Staphylococcus aureus XdrA mutants to investigate the effect on spa transcription
2010-10-11 | E-BUGS-105 | biostudies-arrayexpress
Transcriptomics Transcription profiling by array of Mycobacterium tuberculosis to analyse the regulatory role of the HigA antitoxin
2010-07-16 | E-BUGS-107 | biostudies-arrayexpress
Transcriptomics Transcription profiling by array of Staphylococcus aureus MRSA-252 treated with ranalexin
2011-06-08 | E-BUGS-65 | biostudies-arrayexpress